Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

GasBuddy flags worrisome gas price trend, sends message on what's next

View original at finance.yahoo.com
GasBuddy flags worrisome gas price trend, sends message on what's next The Israel-U.S. war with Iran is proving to be frustrating. Not just for the combatants or the politicians…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Crude oil shortages are growing in gasoline, jet fuel and related products due to insufficient supply

    60% confidence
  • Trump did not know who was really in charge in Iran

    60% confidence
  • Gas prices in California, the highest-priced state, are nearing $6 on average and rising

    60% confidence
  • Prices typically rise in the spring and early summer as U.S. refiners build supply and change their recipes to make gasoline more environmentally friendly

    60% confidence
  • U.S. gas prices jumped from $2.972/gallon on Feb. 28 to $4.167/gallon on April 8, a gain of nearly 40% and an 83% jump for the year

    60% confidence
  • He doesn't see any big price breaks soon. The will to talk just doesn't seem to be there.

    60% confidence
  • Travel time to Islamabad for the negotiation meeting was too great

    60% confidence
  • The cheapest gas in the United States is in Oklahoma, with a statewide average of $3.47

    60% confidence

Data points we hold from this source

United States Government · avg gas price per gallon4.07 USD
United States Government · avg gas price per gallon2.972 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com